The pipeline to new drugs isn’t straightforward. Whilst some estimates of only 5-10% of drug programs making it to approval may be lowballing the true rate, success is still far from guaranteed. What ...

A machine learning-based model that enables medical institutions to predict the mortality risk for individual cardiac surgery patients has been developed by a Mount Sinai research team, providing a ...

Humata Health has received $25 million in a funding round to improve the prior authorization experience for payers and providers. The funding round was led by Blue Venture Fund, the VC arm of most ...